User profiles for Aaron G. Lim
 | Aaron G. LimUniversity of Oxford Verified email at maths.ox.ac.uk Cited by 1324 |
Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Background People who inject drugs (PWID) are at increased risk for HIV and hepatitis C
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Background People who inject drugs (PWID) experience a high prevalence of incarceration
and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after …
and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after …
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
Background WHO aims to eliminate the hepatitis C virus (HCV) as a public health threat by
2030. Injection drug use is an important risk factor for HCV transmission, but its contribution to …
2030. Injection drug use is an important risk factor for HCV transmission, but its contribution to …
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom
Aims To estimate whether opioid substitution treatment (OST) with buprenorphine or methadone
is associated with a greater reduction in the risk of all‐cause mortality (ACM) and opioid …
is associated with a greater reduction in the risk of all‐cause mortality (ACM) and opioid …
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
…, H Fraser, D Stewart, C Arum, AG Lim… - The lancet …, 2023 - thelancet.com
Background Measuring the incidence of HIV and hepatitis C virus (HCV) infection among
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination
AG Lim, H Qureshi, H Mahmood… - International journal …, 2018 - academic.oup.com
Background The World Health Organization (WHO) has developed a global health strategy
to eliminate viral hepatitis. We project the treatment and prevention requirements to achieve …
to eliminate viral hepatitis. We project the treatment and prevention requirements to achieve …
HTLV-I infection: a dynamic struggle between viral persistence and host immunity
Human T-lymphotropic virus type I (HTLV-I) causes chronic infection for which there is no
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T-…
cure or neutralising vaccine. HTLV-I has been clinically linked to the development of adult T-…
Modelling the role of Tax expression in HTLV-I persistence in vivo
Human T-lymphotropic virus type I (HTLV-I) is a persistent human retrovirus characterized
by life-long infection and risk of developing HAM/TSP, a progressive neurological and …
by life-long infection and risk of developing HAM/TSP, a progressive neurological and …
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
CF Aas, JH Vold, S Skurtveit, AG Lim, S Ruths… - … , prevention, and policy, 2020 - Springer
Background Opioid dependence carries the highest disease burden of all illicit drugs. Opioid
agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity …
agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity …
[HTML][HTML] Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review
Background The burden of chronic hepatitis B virus (HBV) varies across the European
Union (EU) and European Economic Area (EEA). Aim We aimed to update the 2017 HBV …
Union (EU) and European Economic Area (EEA). Aim We aimed to update the 2017 HBV …
